ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TNON vs WOK // FORWARD P/E MULTIPLE

Tenon Medical Inc. (NASDAQ) VS. WORK Medical Technology Group LTD (Class A) (NASDAQ) • 15-METRIC TALLY: TNON 3 — WOK 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TNON VS. WOK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TNON WOK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 59.80% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 20.40% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 TNON /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.3 31.5 +2.80 TNON /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.2M $4.5M $721.7K TNON /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TNON REV WOK REV TNON GROSS % WOK GROSS % TNON FCF WOK FCF
FY 2025 $3.9M $13.9M 59.8% — -$11.0M $4.9M
FY 2024 $3.3M $43.5M 52.2% — -$10.1M -$11.5M
FY 2023 $2.9M $8.4M — — -$12.2M $2.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TNON // BETA —
WOK // BETA —